Michael Martin Breen, Executive Chairman/Interim CEO at GT Biopharma, Inc. (GTBP), bought 50,000 shares at $0.50 ($25K) on 2023-04-11, disclosed to the SEC on 2023-04-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.